Moolec Science (MLEC) Depreciation & Amortization (CF) (2022 - 2024)
Moolec Science (MLEC) reported Depreciation & Amortization (CF) of $52621.0 for Q4 2024, up 190.96% on a YoY basis from $18085.0 in Q1 2024, and up 9.39% sequentially from $48102.0 in Q3 2024.
Moolec Science (MLEC) Depreciation & Amortization (CF) (2022 - 2024) Analysis & Trends
Moolec Science (MLEC) has 3 years of Depreciation & Amortization (CF) data on file, last reported at $52621.0 in Q4 2024.
- For the quarter ending Q4 2024, Depreciation & Amortization (CF) rose 190.96% year-over-year to $52621.0; the trailing twelve-month figure through Mar 2026 stood at $52621.0 (changed N/A YoY), and the FY2025 full-year result was $6.0 million, up 3.72% from the prior year.
- Depreciation & Amortization (CF) grew to $52621.0 in Q4 2024, from $48102.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $5.8 million in Q2 2024 to a low of -$6646.0 in Q1 2024.
- A 3-year average of $991370.2 and a median of $18085.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) soared 9460.24% in 2023 and plunged 1663.76% in 2024, its largest moves.
- Tracing MLEC's Depreciation & Amortization (CF) over 3 years: stood at $424.0 in 2022, then soared by 4165.33% to $18085.0 in 2023, then jumped by 190.96% to $52621.0 in 2024.
- Business Quant data shows MLEC's Depreciation & Amortization (CF) at $52621.0 in Q4 2024, $48102.0 in Q3 2024, and $5.8 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 52,621.00 |
| Dec 31, 2024 | 52,621.00 |
| Sep 30, 2024 | 48,102.00 |
| Sep 30, 2024 | 48,102.00 |
| Jun 30, 2024 | 5.81 Mn |
| Jun 30, 2024 | 5.81 Mn |
| Mar 31, 2024 | -6,646.00 |
| Mar 31, 2024 | -6,646.00 |
| Dec 31, 2023 | 18,085.00 |
| Dec 31, 2023 | 18,085.00 |
| Sep 30, 2023 | 40,631.00 |
| Sep 30, 2023 | 40,631.00 |
| Jun 30, 2023 | 4.94 Mn |
| Jun 30, 2023 | 4.94 Mn |
| Mar 31, 2023 | 425.00 |
| Mar 31, 2023 | 425.00 |
| Dec 31, 2022 | 424.00 |
| Dec 31, 2022 | 424.00 |
| Sep 30, 2022 | 425.00 |
| Sep 30, 2022 | 425.00 |